TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ABBOTT LABORATORIES Share Price

Certificat

DE000SQ06P80

Delayed Deutsche Boerse AG 06:56:14 23/05/2024 pm IST
1.08 EUR -6.09% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ABBOTT LABORATORIES
Current month-14.18%
1 month-21.23%
Date Price Change
23/24/23 1.08 -6.09%
22/24/22 1.15 +17.35%
21/24/21 0.98 -2.97%
20/24/20 1.01 -7.34%
17/24/17 1.09 -6.03%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 06:56 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SQ06P8
ISINDE000SQ06P80
Date issued 29/09/2022
Strike 92.54 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.87
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.02
Lowest since issue 0.27
Spread 0.08
Spread %6.84%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.8 USD
Average target price
125.7 USD
Spread / Average Target
+19.91%
Consensus